GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 90 filers reported holding GW PHARMACEUTICALS PLC in Q3 2014. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $262,000 | -97.5% | 2,275 | -96.2% | 0.00% | -97.6% |
| Q3 2018 | $10,346,000 | +25.1% | 59,895 | +1.0% | 0.04% | +13.9% |
| Q2 2018 | $8,271,000 | +86.9% | 59,275 | +49.7% | 0.04% | +44.0% |
| Q4 2016 | $4,426,000 | -36.2% | 39,600 | -24.2% | 0.02% | -35.9% |
| Q3 2016 | $6,935,000 | +50.9% | 52,246 | -21.1% | 0.04% | +11.4% |
| Q4 2015 | $4,597,000 | -46.1% | 66,200 | -29.0% | 0.04% | -50.7% |
| Q3 2015 | $8,525,000 | -24.6% | 93,300 | +1.4% | 0.07% | +1.4% |
| Q2 2015 | $11,301,000 | +39.7% | 92,000 | +3.6% | 0.07% | +16.7% |
| Q1 2015 | $8,092,000 | +57.1% | 88,800 | +16.7% | 0.06% | +57.9% |
| Q4 2014 | $5,150,000 | -0.6% | 76,100 | +18.7% | 0.04% | 0.0% |
| Q3 2014 | $5,182,000 | – | 64,100 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
| Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
| Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
| Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
| Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
| Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
| ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
| AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
| Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
| CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |